Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alpenglow Biosciences has developed a patented AI-powered open-top light-sheet microscopy platform that enables non-destructive digitization of entire tissues in three dimensions. Their Aurora™ system integrates advanced imaging hardware with automated data management and deep-learning-based image analysis to provide unprecedented insight into tissue architecture. The company’s assays—such as the “3D Derm Score” for dermatology and “3D I/O Pro Assay” for immuno-oncology—are currently available for research use only. Five of the top ten pharmaceutical companies are customers or partners. The company has secured over $24M from ARPA-H/NIH grants to accelerate its transition from biopharma research tool to high-impact clinical assay provider.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alpenglow Biosciences.